VCRM Insights

The dashboard displays pharmaceutical sales data and client interaction details within the VCRM Insights platform. The left panel shows information for 'James Gabriel' including email, specialty (Dermatology), target status ('New to Brand'), access level (restricted), affiliations (Centre for Dermatology), primary location (39 Newton Sparta Rd), and affinity indicators represented by orange boxes, plus recent interactions (RAD/DL Interactions). The right panel is segmented into 'Calls (R3M)' showing 44 calls, with most recent and next planned dates. A 'Closed Loop Marketing (R3M)' section displays 5 emails viewed, 7 emails sent, and the last email sent date. There's also 'Lunches (R3M)' section with most recent and next possible dates. Below, 'Netrazine' and 'Strobolin' are highlighted, with their TRX volume (R3M) at 113 (-2%) and 127 (-1%) respectively. Competitor TRX volumes are listed, along with the top 3 payers for each product. For Netrazine, MedCo and Aetna show 'Not Favorable' formulary access, while Cigna is 'Favorable'. For Strobolin, BCBS, Cigna and AIGA all show 'Favorable' formulary access. The 'Plan' sections display formularies access and TRX share change.